Current status and perspectives of cell therapy in Chagas disease

Memorias do Instituto Oswaldo Cruz

Volumn 104, Issue SUPPL. 1, 2009, Pages 325-332

  Soares, Milena Botelho Pereira ^a   dos Santos, Ricardo Ribeiro ^b  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b HOSPITAL SÃO RAFAEL   (Brazil)

Author keywords

Cardiomyopathy; Cellular therapy; Chagas disease; Fibrosis; Stem cells; Tissue inflammation

Indexed keywords

ANIMALIA; PROTOZOA; TRYPANOSOMA CRUZI;

EID: 68949202589     PISSN: 00740276     EISSN: 16788060     Source Type: Journal    
DOI: 10.1590/S0074-02762009000900043     Document Type: Article

References (56)

1. Adachi Y, Imagawa J, Suzuki Y, Yogo K, Fukazawa M, Kuromaru O, Saito Y 2004. G-CSF treatment increases side population cell infiltration after myocardial infarction in mice. J Mol Cell Car-diol 36: 707-710.
2. Alison MR, Islam S 2009. Attributes of adult stem cells. J Pathol 217: 144-160.
3. Ballard VL, Edelberg JM 2008. Stem cells for cardiovascular repair - the challenges of the aging heart. J Mol Cell Cardiol 45: 582-592.
4. Bayes-Genis A, Roura S, Prat-Vidal C, Farré J, Soler-Botija C, de Luna AB, Cinca J 2007. Chimerism and microchimerism of the human heart: evidence for cardiac regeneration. Nat Clin Pract Cardiovasc Med 41: S40-45.
5. Cançado JR 2002. Long term evaluation of etiological treatment of Chagas disease with benznidazole. Rev Inst Med Trop 44: 29-37.
6. Cao F, Lin S, Xie X, Ray P, Patel M, Zhang X, Drukker M, Dylla SJ, Connolly AJ, Chen X, Weissman IL, Gambhir SS, Wu JC 2006. In vivo visualization of embryonic stem cell survival, pro-liferation and migration after cardiac delivery. Circulation 113: 1005-1014.
7. Goldenberg RC, Jelicks LA, Fortes FS, Weiss LM, Rocha LL, Zhao D,Carvalho AC, Spray DC, Tanowitz HB 2008 Bone marrow cell therapy ameliorates and reverses chagasic cardiomyopathy in a mouse model. J Infect Dis 197: 544-547.
8. Guarita-Souza LC, Carvalho KA, Woitowicz V, Rebelatto C, Sene-gaglia A, Hansen P, Miyague N, Francisco JC, Olandoski M, Faria-Neto JR, Brofman P 2006. Simultaneous autologous trans-plantation of cocultured mesenchymal stem cells and skeletal myoblasts improves ventricular function in a murine model of Chagas disease. Circulation 4: 120-124.
9. Harada M, Qin Y, Takano H, Minamino T, Zou Y, Toko H, Ohtsuka M, Matsuura K, Sano M, Nishi J, Iwanaga K, Akazawa H, Ku-nieda T, Zhu W, Hasegawa H, Kunisada K, Nagai T, Nakaya H, Yamauchi-Takihara K, Komuro I 2005. G-CSF prevents cardiac remodeling after myocardial infarctionby activating the Jak-Stat pathway in cardiomyocytes. Nat Med 11: 305-311.
10. Hasegawa H, Takano H, Iwanaga K, Ohtsuka M, Qin Y, Niitsuma Y, Ueda K, Toyoda T, Tadokoro H, Komuro I 2006. Cardioprotective effects of granulocyte colony-stimulating factor in swine with chronic myocardial ischemia. J Am Coll Cardiol 47: 842-849.
11. Higashiyama R, Inagaki Y, Hong YY, Kushida M, Nakao S, Niioka M, Watanabe T, Okano H, Matsuzaki Y, Shiota G, Okazaki I 2007. Bone marrow-derived cells express matrix metalloprotei-nases and contribute to regression of liver fibrosis in mice. Hepa-tology 45: 213-222.
12. Higuchi ML 1997. Chronic chagasic cardiopathy: the product of a turbulent host-parasite relationship. Rev Inst Med Trop São Paulo 39: 53-60.
13. Hodgson DM, Behfar A, Zingman LV, Kane GC, Perez-Terzic C, Alekseev AE, Pucéat M, Terzic A 1994. Stable benefit of em-bryonic stem cell therapy in myocardial infarction. Am J Physiol Heart Circ Physiol 287: H471-479.
14. Jacob JL, Salis FV, Ruiz MA, Greco OT 2007. Labeled stem cells transplantation to the myocardium of a patient with Chagas disease. Arq Bras Cardiol 89: e10-11.
15. Kajstura J, Urbanek K, Rota M, Bearzi C, Hosoda T, Bolli R, Anversa P, Leri A 2008. Cardiac stem cells and myocardial disease. J Mol Cell Cardiol 45: 505-513.
16. Kang S, Yang YJ, Li CJ, Gao RL 2008. Effects of intracoronary autologous bone marrow cells on left ventricular function in acute myocardial infarction: a systematic review and meta-analysis for randomized controlled trials. Coron Artery Dis 19: 327-335.
17. Kawada H, Fujita J, Kinjo K, Matsuzaki Y, Tsuma M, Miyatake H, Muguruma Y, Tsuboi K, Itabashi Y, Ikeda Y, Ogawa S, Okano H, Hotta T, Ando K, Fukuda K 2004. Nonhematopoietic mesenchy-mal stem cells can be mobilized and differentiate into cardiomyo-cytes after myocardial infarction. Blood 104: 3581-3587.
18. Klug MG, Soonpaa MH, Koh GY, Field LJ 1996. Genetically selected cardiomyocytes from differentiating embryonic stem cells form stable intracardiac grafts. J Clin Invest 98: 216-224.
19. Köberle F 1968. Chagas' disease & Chagas' syndromes: the pathology of American trypanosomiasis. Adv Parasitol 6: 63-116.
20. Kocher AA, Schuster MD, Szabolcs MJ, Takuma S, Burkhoff D, Wang J, Homma S, Edwards NM, Itescu S 2001. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 7: 430-436.
21. Laflamme MA, Gold J, Xu C, Hassanipour M, Rosler E, Police S, Muskheli V, Murry CE 2005b. Formation of human myocardium in the rat heart from human embryonic stem cells. Am J Pathol 167: 663-671.
22. Laflamme MA, Murry CE 2005a. Regenerating the heart. Nat Biotechnol 23: 845-856.
23. Le Blanc K, Ringdén O 2007. Immunomodulation by mesenchymal stem cells and clinical experience. J Intern Med 262: 509-525.
24. Leon JS, Daniels MD, Toriello KM, Wang K, Engman DM 2004. A cardiac myosin-specific autoimmune response is induced by im-munization with Trypanosoma cruzi proteins. Infect Immun 72: 3410-3417.
25. Leon JS, Engman DM 2001. Autoimmunity in Chagas heart disease. Int J Parasitol 31: 555-561.
26. Makino S, Fukuda K, Miyoshi S, Konishi F, Kodama H, Pan J, Sano M, Takahashi T, Hori S, Abe H, Hata J, Umezawa A, Ogawa S 1999. Cardiomyocytes can be generated from marrow stromal cells in vitro. J Clin Invest 103: 697-705.
27. Menard C, Hagege AA, Agbulut O, Barro M, Morichetti MC, Bras-selet C, Bel A, Messas E, Bissery A, Bruneval P, Desnos M, Pu-céat M, Menasché P 2005. Transplantation of cardiac-committed mouse embryonic stem cells to infarcted sheep myocardium: a preclinical study. Lancet 366: 1005-1012.
28. Minatoguchi, S, Takemura G, Xue-Hai C, Wang N, Uno Y, Koda M, Arai M, Misao Y, Lu C, Suzuki K, Goto K, Komada A, Takahashi T, Kosai K, Fujiwara T, Fujiwara H 2004. Acceleration of the healing process and myocardial regeneration may be important as a mechanism of improvement of cardiac function and remodeling by postinfarction granulocyte colony-stimulating factor treatment. Circulation 109: 2572-2580.
29. Moreira DR, Leite AC, Ribeiro dos Santos R, Soares MB 2009. Approaches for the development of new anti-Trypanosoma cruzi agents. Curr Drug Targets 10: 212-231.
30. Olivares EL, Ribeiro VP, Werneck de Castro JPS, Ribeiro KC, Mattos EC, Goldenberg RC, Mill JG, Dohmann HF, Ribeiro dos Santos R, de Carvalho AC, Masuda MO 2004. Bone marrow stromal cells improve cardiac performance in healed infarcted rat hearts. Am J Physiol Heart Circ Physiol 287: H464-H470.
31. Oliveira SA, Souza BS, Guimaraes-Ferreira CA, Barreto ES, Souza SC, Freitas LA, Ribeiro dos Santos R, Soares MB 2008. Therapy with bone marrow cells reduces liver alterations in mice chroni-cally infected by Schistosoma mansoni. World J Gastroenterol 14: 5842-5850.
32. Orlic D, Kajstura J, Chimenti S, Bodine DM, Leri A, Anversa P 2001. Bone marrow cells regenerate infarcted myocardium. Nature 410: 701-705.
33. Ott HC, Matthiesen TS, Goh SK, Black LD, Kren SM, Netoff TI, Taylor DA 2008. Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart. Nat Med 14: 213-221.
34. Perino MG, Yamanaka S, Li J, Wobus AM, Boheler KR 2008. Cardiomyogenic stem and progenitor cell plasticity and the dissection of cardiopoiesis. J Mol Cell Cardiol 45: 475-494.
35. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR 1999. Multilineage potential of adult human mesenchymal stem cells. Science 284: 143-147.
36. Pontes-de-Carvalho L, Santana CC, Soares MBP, Oliveira GG, Cunha-Neto E, Ribeiro dos Santos R 2002. Experimental chronic Chagas' disease myocarditis is an autoimmune disease prevent-able by induction of immunological tolerance to myocardial antigens. J Autoimmun 18: 131-138.
37. Reinecke H, MacDonald GH, Hauschka SD, Murry CE 2000. Electro-mechanical coupling between skeletal and cardiac muscle. Impli-cations for infarct repair. J Cell Biol 149: 731-740.
38. Ribeiro dos Santos R, Mengel JO, Postol E, Soares RA, Ferreira-Fernandez E, Soares MB, Pontes-De-Carvalho LC 2001. A heart-specific CD4+T-cell line obtained from a chronic chagasic mouse induces carditis in heart-immunized mice and rejection of normal heart transplants in the absence of Trypanosoma cruzi. Parasite Immunol 23: 93-101.
39. Ribeiro dos Santos R, Rossi MA, Laus JL, Silva JS, Savino W, Mengel J 1992. Anti-CD4 abrogates rejection and reestablishes long-term tolerance to syngeneic newborn hearts grafted in mice chroni-cally infected with Trypanosoma cruzi. J Exp Med 175: 29-39.
40. Robey TE, Saiget MK, Reinecke H, Murry CE 2008. Systems ap-proaches to preventing transplanted cell death in cardiac repair. J Mol Cell Cardiol 45: 567-581.
41. Rocha NN, Garcia S, Gimenez LE, Hernández CC, Senra JF, Lima RS, Cyrino F, Bouskela E, Soares MB, Ribeiro dos Santos R, Campos de Carvalho AC 2006. Characterization of cardiopul-monary function and cardiac muscarinic and adrenergic receptor density adaptation in C57BL/6 mice with chronic Trypanosoma cruzi infection. Parasitology 133: 729-737.
42. Scorsin M, Hagège A, Vilquin JT, Fiszman M, Marotte F, Samuel JL, Rappaport L, Schwartz K, Menasché P 2000. Comparison of the effects of fetal cardiomyocyte and skeletal myoblast transplanta-tion on postinfarction left ventricular function. J Thorac Cardio-vasc Surg 119: 1169-1175.
43. Soares MB, Garcia S, Campos de Carvalho AC, Ribeiro dos Santos R 2007. Cellular therapy in Chagas' disease: potential applications in patients with chronic cardiomyopathy. Regen Med 2: 257-264.
44. Soares MBP, Lima RS, Rocha LL, Takyia CM, Pontes-de-Carvalho L, de Carvalho AC, Ribeiro dos Santos R 2004. Transplanted bone marrow cells repair heart tissue and reduce myocarditis in chronic chagasic mice. Am J Pathol 164: 441-447.
45. Soares MBP, Pontes-de-Carvalho L, Ribeiro dos Santos R 2001. The pathogenesis of Chagas' disease: when autoimmune and para-site-specific immune responses meet. An Acad Bras Cienc 73: 547-559.
46. Takahashi K, Okita K, Nakagawa M, Yamanaka S 2007. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131: 861-872.
47. Takahashi K, Yamanaka S 2006. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126: 663-676.
48. Tarleton RL 2001. Parasite persistence in the aetiology of Chagas dis-ease. Int J Parasitol 31: 550-554.
49. Taylor DA, Zenovich AG 2008. Cardiovascular cell therapy and en-dogenous repair. Diabetes Obes Metab 10: 5-15.
50. ten Hove WR, Verspaget HW, Barge R, Lamers CB, van Hoek B 2007. Liver chimerism after allogeneic blood stem cell transplantation. Transplant Proc 39: 231-236.
51. Toma C, Pittenger MF, Cahill KS, Byrne BJ, Kessler PD 2002. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 105: 93-98.
52. Tura BR, Martino HF, Gowdak LH, Ribeiro dos Santos R, Dohmann HF, Krieger JE, Feitosa G, Vilas-Boas F, Oliveira SA, Silva SA,Bozza AZ, Borojevic R, Campos de Carvalho AC 2007. Multicenter randomized trial of cell therapy in cardiopathies - MiHeart Study. Trials 8: 2.
53. Vilas-Boas F, Feitosa GS, Soares MBP, Mota A, Pinho-Filho JA, Gonçalves Almeida AJ, Andrade MV, Carvalho HG, Dourado-Oliveira A, Ribeiro dos Santos R 2006. Early results of bone mar-row cell transplantation to the myocardium of patients with heart failure due to Chagas disease. Arq Bras Cardiol 87: 159-166.
54. Vilas-Boas F, Feitosa GS, Soares MB, Pinho-Filho JA, Mota A, Al-meida AJ, Carvalho C, de Carvalho HG, de Oliveira AD, Ribeiro dos Santos R 2004. Bone marrow cell transplantation to the myo-cardium of a patient with heart failure due to Chagas' disease. Arq Bras Cardiol 82: 185-187.
55. Wang JS, Shum-Tim D, Chedrawy E, Chiu RC 2001. The coronary delivery of marrow stromal cells for myocardial regeneration: pathophysiologic and therapeutic implications. J Thorac Cardio-vasc Surg 122: 699-705.
56. Zhang J, Wilson GF, Soerens AG, Koonce CH, Yu J, Palecek SP, Thom-son JA, Kamp TJ 2009. Functional cardiomyocytes derived from human induced pluripotent stem cells. Circ Res 104: e30-41.